コンテンツへスキップ
· ダーマルフィラー
SKU 11239

Yvoire Y-Solution 360

In stock
Volume
1 x 1 mL
Laboratory
LG Chem
Origin
韓国
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.

主なメリット: Yvoire Y-Solution 360

  • Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
  • Provides flexible projection and is designed to resist the dynamics of facial expression
  • Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
  • Built on the manufacturer's S-HICE cross-linking process
  • Supports anti-ageing aesthetic treatment approaches
  • Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
  • Supplied with two Terumo thin-wall 29G needles
主な情報
ブランド YVOIRE
製造元 LG Chem
原産国 South Korea
成分 Cross-linked hyaluronic acid 12 mg/mL, lidocaine 0.3%
包装 1 syringe x 1 mL with two Terumo thin-wall 29G needles enclosed
使用タイプ Professional use only: injectable dermal filler with anaesthetic
注入の深さ Facial skin layer

適応と専門的な使用

主な適応

  • Anti-ageing aesthetic treatment
  • Facial projection support
  • Treatments requiring flexibility and cohesion

専門的な使用

Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.

施術部位

  • Face

対象となる患者

Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.

作用の仕組み: Yvoire Y-Solution 360 ​

Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.

Allparaで注文する理由

Allparaは、正規品で検証済みの YVOIRE 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。

よくある質問

What is in Yvoire Y-Solution 360?

Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.

How does Yvoire Y-Solution 360 differ from Yvoire Y-Solution 540 and Yvoire Y-Solution 720?

Yvoire Y-Solution 360 is 12 mg/mL with 29G needles. Yvoire Y-Solution 540 and Yvoire Y-Solution 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.

その他の製品: LG Chem

View laboratory

Clinic alternatives

All products

Yvoire Y-Solution 360

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Yvoire Y-Solution 360 is a cross-linked hyaluronic acid dermal filler manufactured in South Korea as part of the YVOIRE Y-Solution range, which is built on a synergy between elasticity and cohesion that gives the gel spring-like characteristics for flexibility, projection and resistance to the dynamics of facial expression. The Y-Solution numbers are lift tiers rather than concentrations, and the 360 is the lightest gel in the entire Yvoire range. The product contains cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine and is intended for professional use by qualified practitioners only. It is supplied as a single 1 mL syringe with two Terumo thin-wall 29G needles enclosed; its shelf life is 17 months, shorter than the 24 months of the Classic, Volume and Contour references, so check the date when rotating stock.

主なメリット: Yvoire Y-Solution 360

  • Combines elasticity and cohesion, which the manufacturer describes as spring-like characteristics
  • Provides flexible projection and is designed to resist the dynamics of facial expression
  • Cross-linked hyaluronic acid at 12 mg/mL with 0.3% lidocaine, the lightest gel in the Yvoire range
  • Built on the manufacturer's S-HICE cross-linking process
  • Supports anti-ageing aesthetic treatment approaches
  • Part of the Y-Solution 360, 540 and 720 range, where the number is a lift tier rather than a concentration
  • Supplied with two Terumo thin-wall 29G needles
主な情報
ブランド YVOIRE
製造元 LG Chem
原産国 South Korea
成分 Cross-linked hyaluronic acid 12 mg/mL, lidocaine 0.3%
包装 1 syringe x 1 mL with two Terumo thin-wall 29G needles enclosed
使用タイプ Professional use only: injectable dermal filler with anaesthetic
注入の深さ Facial skin layer

適応と専門的な使用

主な適応

  • Anti-ageing aesthetic treatment
  • Facial projection support
  • Treatments requiring flexibility and cohesion

専門的な使用

Yvoire Y-Solution 360 is intended for administration by qualified medical practitioners trained in dermal filler injection technique, using aseptic technique. The manufacturer gives the application zone as the face and the injection site as the facial skin layer, and encloses two Terumo thin-wall 29G needles, a notably fine gauge that reflects a lighter gel than the Volume and Contour references in the range. This reference contains 0.3% lidocaine, so patients must be screened for sensitivity to amide-type local anaesthetics before treatment. Injection technique and volume per treatment area are determined by the practitioner.

施術部位

  • Face

対象となる患者

Suitable for adult patients seeking anti-ageing correction where flexibility and resistance to facial movement matter, as assessed by a qualified practitioner. At 12 mg/mL this is the lightest gel in the whole Yvoire range, well below the 20 to 22 mg/mL of the Volume and Contour references, so patients seeking structural contouring of the chin or nose, or correction of deep folds, are better served by those products. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates.

作用の仕組み: Yvoire Y-Solution 360 ​

Yvoire Y-Solution 360 works through cross-linked hyaluronic acid at 12 mg/mL (1.2%), made by the manufacturer's S-HICE process and formulated for what it describes as a synergy between elasticity and cohesion. The intended effect is spring-like: the gel flexes with the face rather than resisting it, which is why the range is positioned around projection that survives the dynamics of facial expression rather than around static filling. At 12 mg/mL this is the lightest gel in the Yvoire range, against 20 to 22 mg/mL for the Volume and Contour references, and the two Terumo thin-wall 29G needles enclosed reflect that. The 0.3% lidocaine acts locally to improve comfort during injection.

Allparaで注文する理由

Allparaは、正規品で検証済みの YVOIRE 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。

よくある質問

What is in Yvoire Y-Solution 360?

Cross-linked hyaluronic acid at 12 mg/mL (1.2%) with 0.3% lidocaine. Patients should be screened for sensitivity to amide-type local anaesthetics beforehand.

How does Yvoire Y-Solution 360 differ from Yvoire Y-Solution 540 and Yvoire Y-Solution 720?

Yvoire Y-Solution 360 is 12 mg/mL with 29G needles. Yvoire Y-Solution 540 and Yvoire Y-Solution 720 both state 20 mg/mL with 0.3% lidocaine and two 27G needles, and are positioned at different lift levels rather than different concentrations. All three share the same elasticity and cohesion concept, and the numbers are lift tiers rather than concentrations.

その他の製品: LG Chem

ラボを見る →
* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.